von Groote T

Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial).

Mazer CD, Siadati-Fini N, Boehm J, ..., Ronco C, Zarbock A

BMJ Open 13 (4) e068363 [2023-04-06; online 2023-04-06]

Category: Health Type: Journal article